Trial NCT00720629

View at ClinicalTrials.gov 
Org. Study IDs: MCC-15033
Secondary IDs: R01CA132197-06A2

Last trial update was posted on 2014-07-18

MeSH Interventions

Antilymphocyte Serum Methotrexate Tacrolimus Thymoglobulin Visilizumab

MeSH Conditions

Graft vs Host Disease

Other Conditions

Graft Versus Host Disease

Stopping Reasons

N/A

Limitations And Caveats

Study closed early during the first stage, did not proceed to the second stage comparison as planned. Investigators exercised right to close the study prematurely for lack of efficacy, although no protocol-defined end points had been met.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID